Skip to content

Study on the application of artificial intelligence assisted technology in the surgical treatment of thymic diseases

Artificial intelligence assisted technology may improve the accuracy of preoperative indication diagnosis of thymus surgery with double elevated subxiphoid process

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037334
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-09-17
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thymic tumor

Interventions

1:Artificial intelligence assisted thoracoscopic thymectomy under xiphoid process with double hook suspension sternum
2:Main outcome indicators of conventional thoracoscopic thymectomy

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: A total of 100 patients who underwent thoracoscopic thymectomy in the Department of thoracic surgery of Shanghai Pulmonary Hospital within 24 months were collected. 1) Preoperative evaluation, Masaoka stage I-II thymoma patients; 2) MG patients (with or without thymus hyperplasia, thymoma or other anterior mediastinal diseases); 3) Patients with normal cardiac function, 20-70 years old and BMI < 30 before operation.

Exclusion criteria

Exclusion criteria: 1) Patients who cannot tolerate surgery; 2) Patients with myasthenia crisis; 3) Preoperative evaluation, Masaoka stage III-IV thymoma patients; 4) Patients with chronic pain or long-term use of opioid analgesics before operation; 5) Preoperative examination of patients with mental disorders such as excessive anxiety; 6) Patients with previous anterior mediastinal surgery or cardiac surgery; 7) Patients with thoracic deformity (e.g. pectus excavatum and chicken chest); 8) Those with low education level could not understand the requirements of postoperative follow-up and evaluation scale.

Design outcomes

Primary

MeasureTime frame
Thymectomy rate;

Secondary

MeasureTime frame
pain score;

Countries

China

Contacts

Public ContactJiang Fan

Shanghai Pulmonary Hospital

fan_jiang@tongji.edu.cn+86 15901013210

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026